Abstract:Objective Cardioneuroablation (CNA) is effective for cardiac inhibitory and mixed vasovagal syncope (VVS) but not vasodepressor VVS. This study aimed to assess the therapeutic benefits of CNA in vasodepressor VVS. Methods VVS patients hospitalized in the Department of Cardiology of Jiangxi Provincial People’s Hospital were retrospectively reviewed. Holter monitoring was performed before, during, and 3 months after CNA. Changes in heart rate and Wenckebach point of atrioventricular conduction before and after ablation were compared. Results Thirty-five patients were enrolled, 18 men and 17 women. Mean age was 47.48 ± 16.49 years. Median duration of syncope was 24.0 months (range, 2.5–66.0). Median number of syncope episodes before treatment was two (range, 2–4). The time domain indexes of heart rate variability, mean heart rate, maximum heart rate, and minimum heart rate were significantly higher 3 months after CNA. Mean follow-up was 11 ± 4.67 months. Recurrent syncope occurred in two patients with vasodepressor VVS, one of them with presyncope symptoms in vasodepressor type; and one patient occurred with mixed VVS, without presyncope symptoms. No serious complications occurred. CNA is safe and effective in the treatment of vasodepressor VVS. Conclusions CNA is effective for treating vasodepressor VVS. Our study provides a theoretical basis for individualization of treatment in patients with vasodepressor VVS. ### Competing Interest Statement The authors have declared no competing interest. ### Clinical Trial This is a retrospective study ### Funding Statement This work was supported by grants from the National Natural Science Foundation of China (82000276), Supported by Administration of Traditional Chinese Medicine of Jiangxi Province (2020A0148), Grant for Science and Technology Project of Jiangxi Provincial Health Commission (202310005). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethics Committee of Jiangxi Provincial People's Hospital I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Evaluation of Cilazapril in Vasovagal Syncope Treatment

Selective Anatomical Catheter Ablation of Left Atrial Ganglionated Plexus for Vasovagal Syncope: Left Superior and Right Anterior Ganglionated Plexus Ablation

Effect of Valsartan on the Level of Vwf in Patients with Hypertension and Metabolic Syndrome

Clinical Observation of Irbesartan in Treatment of Vasovagal Syncope

Efficacy of Cardioneurablation for Vasodepressor Vasovagal Syncope

The value of TT for diagnosing vasovagal syncope in children and the clinical efficacy of drinking-water

[Hemodynamic Changes During Head-Up Tilt Test and Predictive Value Thereof in Predicting the Efficacy of Metoprolol Therapy in Children with Vasovagal Syncope].

Effect of psychotherapy on recurrence of events and quality of life in patients with vasovagal syncope

A higher peak heart rate during head-up tilt test predicts the therapeutic efficacy of metoprolol in vasovagal syncope

Efficacy of Increased Salt and Water Intake on Pediatric Vasovagal Syncope: A Meta-Analysis Based on Global Published Data

[Meta-Analysis of Beta-Adrenoceptor Blockers for the Treatment of Vasovagal Syncope].

Changes of plasma endothelin, EDRF and heart rate variability during the table tilt test in patients with vasovagal syncope

Effect of Shenfu Injection on Prognosis and Quality of Life of Patients with Vasovagal Syncope

Follow-up study of the efficacy of different therapies on vasovagal syncope in children with different hemodynamic patterns

Clinical Efficacy of Catheter Ablation in the Treatment of Vasovagal Syncope

Serotonin reuptake inhibition for the prevention of vasovagal syncope: a systematic review and meta-analysis

The role of serotonin and serotonergic-related metabolites in pathogenesis of vasovagal syncope

Effectiveness analysis of deceleration capacity and traditional heart rate variability in diagnosing vasovagal syncope

Clinical Efficacy of Empirical Therapy in Children with Vasovagal Syncope

Management of patients with Reflex Vasovagal syncope with a protocol involving a yoga maneuver Tadasana

Autonomic control of vasovagal syncope